PitchSend

Investor Presentaiton

Coloplast has strong market positions in Europe and great commercial potential outside Europe Europe Other developed Emerging Ostomy Care Continence Care Voice & Respiratory Care (Laryngectomy) Interventional Urology Wound Care (Adv. Dressings)* Addressable market Size in DKK Growth in %* 20-21bn 4-5% 15-16bn 5-6% 1-1.5bn 8-10% 13-14bn 3-5% 24-26bn 2-4% Coloplast total 35-40% 40 - 45% market share -85% Coloplast 40-50% regional market 15-25% 45-55% 25-35% shares 45-55% 40 - 50% Hollister Key competitors convatec -forever caring- 15 - 20% 5-10% Wellspect HEALTHCARE BARD Hollister 80-90% 80-90% 95 - 100% FAHL INHEALTH 20-25% 15-20% 5-10% • • Penetrate "white-space" Reimbursement in new geographies Compliant usage Key drivers and limiters 21 Ageing population • Increasing access to healthcare Health care reforms • Re-use of products outside Europe • IC penetration potential • • Ageing population Up-selling Health care reforms Commoditization *The Wound Care market above only includes the Advanced Dressings market, where Coloplast is present today. With the acquisition of Kerecis, Coloplast enters the Biologics wound care segment, with an estimated market size of around DKK 15 billion and a high-single digit growth rate • New portfolio Provox Life™ Boston Scientific Advancing science for life" COOK MEDICAL дад BD Ageing, obesity • Under penetration • Cost consciousness Clinical requirements • Less invasive/office procedures 5-10% 0-5% 5-10% convatec -forever caring- smith&nephew 3M Mölnlycke • Ageing, obesity, diabetes •New technologies • • Healthcare reforms Competition • Community treatment Coloplast

View entire presentation